Nosa Med AB (NOSA) — Cash Flow-to-Debt Ratio
Latest as of December 2025:
-0.08x
Nosa Med AB (NOSA) has a Cash Flow-to-Debt Ratio of -0.08x as of December 2025, meaning its operating cash flow of Skr-1.78 Million could theoretically repay 0% of its total liabilities (Skr23.65 Million) in one year. See NOSA FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
-0.08x
Operating CF / Total Liabilities
Operating Cash Flow
Skr-1.78 Million
SEK
Total Liabilities
Skr23.65 Million
SEK
Data as of
Dec 2025
Most recent filing
Nosa Med AB Cash Flow-to-Debt Ratio (2016–2025)
Historical debt coverage capacity for Nosa Med AB across 10 annual periods. Also explore NOSA net asset momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Nosa Med AB (2016–2025)
Year-by-year debt coverage analysis for Nosa Med AB. For market capitalisation and broader financial context, see NOSA company net worth.
| Year | CF-to-Debt Ratio | Operating CF (SEK) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.27x | Skr-6.39 Million | Skr23.65 Million | ▲ +88.8% |
| 2024 | -2.42x | Skr-10.03 Million | Skr4.14 Million | ▲ +12.4% |
| 2023 | -2.76x | Skr-17.50 Million | Skr6.33 Million | ▼ -33.0% |
| 2022 | -2.08x | Skr-6.93 Million | Skr3.33 Million | ▲ +67.2% |
| 2021 | -6.33x | Skr-6.21 Million | Skr980.00K | ▼ -32.3% |
| 2020 | -4.79x | Skr-69.96 Million | Skr14.61 Million | ▼ -43.4% |
| 2019 | -3.34x | Skr-52.72 Million | Skr15.79 Million | ▼ -35.2% |
| 2018 | -2.47x | Skr-35.09 Million | Skr14.21 Million | ▲ +33.4% |
| 2017 | -3.71x | Skr-27.78 Million | Skr7.49 Million | ▲ +43.2% |
| 2016 | -6.53x | Skr-23.48 Million | Skr3.60 Million | — |
Cash Flow-to-Debt Ratio = Operating Cash Flow / Total Liabilities. Higher is better for debt service capacity.